F S&P 500
5,204.25 -8.50 (-0.16%) F Dow Jones
39,133.00 -62.00 (-0.16%) F Nasdaq
18,149.50 -37.00 (-0.20%) E-mini Russell 2000 Index Futur
2,057.30 -7.50 (-0.36%) Petróleo
79.66 +0.67 (+0.85%) Oro
2,316.50 -5.80 (-0.25%)
NutraLife BioSciences, Inc. (NLBS)
NutraLife BioSciences, Inc.
6601 Lyons Road
Suite L-6
Coconut Creek, FL 33073
United States
888 509 8901
https://www.nutralifebiosciences.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 12
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Edgar Ward | Founder, President, CEO & Director | 350k | N/D | 1972 |
| Mr. Nicholas E Ward | Project & Operations Manager | N/D | N/D | N/D |
| Dr. Kenneth L Duchin Ph.D. | Chief Clinical Developer | N/D | N/D | N/D |
| Dr. Hongxiang Hui M.D., Ph.D. | Chief Medical Advisor & Member of Advisory Board | N/D | N/D | N/D |
Descripción
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.
Gestión corporativa
La calificación ISS Governance QuickScore de NutraLife BioSciences, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
